Mapp Biopharmaceutical   Report issue

For profit Phase 1
Founded: San Diego CA United States (2003)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2016
NCT02579083
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

LeafBio, Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

mb66 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Herpes Simplex (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1